Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,238.00
Bid: 12,236.00
Ask: 12,238.00
Change: 68.00 (0.56%)
Spread: 2.00 (0.016%)
Open: 12,114.00
High: 12,254.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Pound firms, lifted by soothing Omicron news, higher gilt yields

Thu, 23rd Dec 2021 11:24

(Updates throughout, adds chart, quotes)

By Sujata Rao

LONDON, Dec 23 (Reuters) - Sterling rose to one-month highs
against the dollar and euro on Thursday, benefiting from some
reassuring reports on the Omicron COVID-19 variant and a move
higher in Britain's short-dated government bond yields.

A three-dose course of AstraZeneca's COVID-19
vaccine is effective against Omicron, the company said, citing
data from an Oxford University study. Its findings match those
from rivals Pfizer-BioNTech and Moderna, which say a third shot
of their vaccines works against Omicron.

Coming on top of reports that Omicron patients are less
likely to need hospitalisation, the news raised hopes that
governments may not need to widen restrictions on activities,
allowing economies to recover.

Britain also cut its COVID-19 self-isolation period to seven
days from 10 days for those who test negative two days in a row.

UK businesses posted the weakest quarterly growth since the
three months to April when lockdowns were in effect, the
Confederation of British Industry (CBI) said.

By 1030 GMT, the pound rose 0.4% to the dollar at $1.3380,
just off a one-month peak of $1.33875 hit earlier.
Against the euro, it firmed to the highest in a month, up 0.4%
to 84.45 pence.

UK gilt yields rose too, outstripping German and U.S. peers,
with 10-year yields up 4.5 basis points and two-year yields
hitting the highest since early November.

Nomura strategist Jordan Rochester noted a pickup in UK
"real" or inflation-adjusted yields. British 5-year real yields
are up some 60 basis points since mid-December. while its U.S.
and German counterparts have flatlined, Refinitiv data shows,

"If you're looking for why sterling remains bid, it's the
continued pickup in real yields," Rochester said, though he
suggested the moves were attributed more to Christmas volumes
"rather than the start of a new uptrend" with the positive
impulse from BOE rate hikes already largely priced in.

Money markets are factoring in 100 basis points of rate
hikes from the BOE in 2022 but Rochester noted headwinds to UK
growth from soaring gas prices and full EU customs controls
kicking in from Jan. 1.

The pound has risen 1.6% to the dollar since Dec. 15, just
before a surprise Bank of England interest rate hike.

Societe Generale analysts said the latest pound gains had
also kicked off as the dollar failed to break above $1.32 on
Wednesday, triggered short-covering.

More positive Omicron news may be needed to fuel further
significant moves, they added.

(Reporting by Sujata Rao; Editing by Catherine Evans and
Bernadette Baum)

More News
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.